Chemed Corporation
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 12 →InsidersNo open-market buys. 4 insiders sold $3.9M, 0 of 7 sales on a 10b5-1 plan.→HoldersBlackRock 3.9%AQR 2.6%Vanguard Portfolio 2.1%→PeersClosest companies: PNTG, NHC, AVAH→
From the filings
Figures
- Revenue
- $2.60Blast 12 months
- Net income
- $10.0Mlast 12 months
- Operating cash flow
- $443.7Mlast 12 months
- Cash and equivalents
- $40.2Mat the last balance sheet
- Total debt
- $140.0Mat the last balance sheet
- Shares outstanding
- 37.6M shareson issue